GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hester Biosciences Ltd (NSE:HESTERBIO) » Definitions » Float Percentage Of Total Shares Outstanding

Hester Biosciences (NSE:HESTERBIO) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 31, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hester Biosciences Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hester Biosciences's float shares is 0.00 Mil. Hester Biosciences's total shares outstanding is 8.51 Mil. Hester Biosciences's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hester Biosciences's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hester Biosciences's Institutional Ownership is 13.39%.


Hester Biosciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Hester Biosciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/8.51
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hester Biosciences Business Description

Industry
Traded in Other Exchanges
Address
Motilal Hirabhai Road, Pushpak, 1st Floor, Panchvati Circle, Ahmedabad, GJ, IND, 380006
Hester Biosciences Ltd is an India based animal healthcare company. The company's operating segment includes Poultry Healthcare, Animal Healthcare, Petcare and Others. It generates maximum revenue from the Poultry Healthcare segment. The company's products are used to cure poultry diseases such as Fowl Pox, Newcastle Disease, Infectious Bronchitis and others. Geographically, it sells the products in India and also exports them to other countries, of which key revenue is derived from India.

Hester Biosciences Headlines

No Headlines